Skip to main content

Animations

MJFF Publications

5971 - 5980 of 6403 Results
Title
Year
  • Year
  • 2024
  • 2017
  • 2021
  • 2018
  • 2020
  • 2023
  • 2009
  • 2019
  • 2016
  • 2021
  • Summary Details
    OPEN
    Title: Pharmacological targeting of dopamine D1 or D2 receptors evokes a rapid‐onset parkinsonian motor phenotype in mice
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16622
    Citation Count: 3
  • Summary Details
    OPEN
    Title: 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2017.00272
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils
    Journal Name: Molecular Imaging
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1536012118796297
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-02338-1
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2008.12.010
    Citation Count: 225
  • Summary Details
    OPEN
    Title: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survival
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24852
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2021.626128
    Citation Count: 81
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.